Factor XIII Subunit A in the Skin: Applications in Diagnosis and Treatment

Lilla Paragh1, Daniel Törőcsik1

  • 1Department of Dermatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.

Insights

Factor XIII subunit A (FXIII-A) has roles beyond blood clotting, acting as a diagnostic marker in skin diseases. This review explores its functions, sources, and implications in skin health and healing.

Area of Science:

  • Dermatology
  • Cell Biology
  • Biochemistry

Background:

  • Factor XIII subunit A (FXIII-A) is traditionally known for its role in hemostasis.
  • FXIII-A is increasingly recognized for its intracellular presence and diagnostic utility in various dermatological conditions, including inflammatory diseases and malignancies.
  • The precise interpretation of dermal cell types expressing FXIII-A and the mechanisms of its accumulation remain subjects of ongoing research.

Purpose of the Study:

  • To provide a comprehensive guide to the interpretation of dermal cell types expressing FXIII-A.
  • To assess the mechanisms of FXIII-A accumulation in human skin under physiological and pathological conditions.
  • To summarize the intracellular functions and extracellular sources of FXIII-A in the dermis, focusing on its relevance to skin homeostasis and disease.

Main Methods:

  • This review synthesizes existing literature on FXIII-A.
  • It analyzes studies investigating FXIII-A expression in various skin cells.
  • Mechanisms of FXIII-A regulation and function in dermal contexts are assessed.

Main Results:

  • FXIII-A expression is observed in diverse dermal cell types, with varying interpretations.
  • Mechanisms for FXIII-A accumulation involve both endogenous production and extracellular deposition.
  • FXIII-A plays a role in intracellular processes and extracellular matrix modulation within the skin.

Conclusions:

  • FXIII-A is a significant factor in skin homeostasis and pathogenesis of dermatological diseases.
  • Understanding FXIII-A's diverse roles offers insights into disease mechanisms.
  • FXIII-A holds potential therapeutic implications for wound healing and other skin conditions.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
397
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.6K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
13.8K
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
11.1K